169 related articles for article (PubMed ID: 21270668)
1. A practical guide of the Southwest Oncology Group to measure malignant pleural mesothelioma tumors by RECIST and modified RECIST criteria.
Tsao AS; Garland L; Redman M; Kernstine K; Gandara D; Marom EM
J Thorac Oncol; 2011 Mar; 6(3):598-601. PubMed ID: 21270668
[TBL] [Abstract][Full Text] [Related]
2. CT, RECIST, and malignant pleural mesothelioma.
Nowak AK
Lung Cancer; 2005 Jul; 49 Suppl 1():S37-40. PubMed ID: 15950799
[TBL] [Abstract][Full Text] [Related]
3. Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1).
Armato SG; Nowak AK
J Thorac Oncol; 2018 Jul; 13(7):1012-1021. PubMed ID: 29753121
[TBL] [Abstract][Full Text] [Related]
4. A practical guide to measure "all" malignant pleural mesothelioma tumors by modified RECIST criteria?
Nackaerts K; Vansteenkiste J; Nafteux P
J Thorac Oncol; 2011 Dec; 6(12):2143-4; author reply 2144-5. PubMed ID: 22088994
[No Abstract] [Full Text] [Related]
5. Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma.
van Klaveren RJ; Aerts JG; de Bruin H; Giaccone G; Manegold C; van Meerbeeck JP
Lung Cancer; 2004 Jan; 43(1):63-9. PubMed ID: 14698538
[TBL] [Abstract][Full Text] [Related]
6. Assessment of tumor response in malignant pleural mesothelioma.
Ceresoli GL; Chiti A; Zucali PA; Cappuzzo F; De Vincenzo F; Cavina R; Rodari M; Poretti D; Lutman FR; Santoro A
Cancer Treat Rev; 2007 Oct; 33(6):533-41. PubMed ID: 17764849
[TBL] [Abstract][Full Text] [Related]
7. From the archives of the AFIP. Malignant pleural mesothelioma: radiologic-pathologic correlation.
Miller BH; Rosado-de-Christenson ML; Mason AC; Fleming MV; White CC; Krasna MJ
Radiographics; 1996 May; 16(3):613-44. PubMed ID: 8897628
[TBL] [Abstract][Full Text] [Related]
8. Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT.
Plathow C; Klopp M; Thieke C; Herth F; Thomas A; Schmaehl A; Zuna I; Kauczor HU
Eur Radiol; 2008 Aug; 18(8):1635-43. PubMed ID: 18369634
[TBL] [Abstract][Full Text] [Related]
9. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
Sharif S; Zahid I; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493
[TBL] [Abstract][Full Text] [Related]
10. Observer variability in mesothelioma tumor thickness measurements: defining minimally measurable lesions.
Armato SG; Nowak AK; Francis RJ; Kocherginsky M; Byrne MJ
J Thorac Oncol; 2014 Aug; 9(8):1187-94. PubMed ID: 25157772
[TBL] [Abstract][Full Text] [Related]
11. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma.
Byrne MJ; Nowak AK
Ann Oncol; 2004 Feb; 15(2):257-60. PubMed ID: 14760119
[TBL] [Abstract][Full Text] [Related]
12. Use of imaging in the management of malignant pleural mesothelioma.
Benamore RE; O'Doherty MJ; Entwisle JJ
Clin Radiol; 2005 Dec; 60(12):1237-47. PubMed ID: 16291305
[TBL] [Abstract][Full Text] [Related]
13.
Niccoli Asabella A; Di Palo A; Altini C; Fanelli M; Ferrari C; Lavelli V; Ranieri G; Gadaleta CD; Rubini G
Hell J Nucl Med; 2018; 21(3):191-197. PubMed ID: 30411729
[TBL] [Abstract][Full Text] [Related]
14. Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?
Frauenfelder T; Tutic M; Weder W; Götti RP; Stahel RA; Seifert B; Opitz I
Eur Respir J; 2011 Jul; 38(1):162-8. PubMed ID: 21273389
[TBL] [Abstract][Full Text] [Related]
15. [Asbestos-induced malignant pulmonary and pleural diseases].
Duell T
MMW Fortschr Med; 2011 Jun; 153(22):38-41. PubMed ID: 21682033
[No Abstract] [Full Text] [Related]
16. Computed tomography in the evaluation of malignant pleural mesothelioma-Association of tumor size to a sarcomatoid histology, a more advanced TNM stage and poor survival.
Paajanen J; Laaksonen S; Ilonen I; Wolff H; Husgafvel-Pursiainen K; Kuosma E; Ollila H; Myllärniemi M; Vehmas T
Lung Cancer; 2018 Feb; 116():73-79. PubMed ID: 29413055
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma.
Genestreti G; Moretti A; Piciucchi S; Tiseo M; Bersanelli M; Scarlattei M; Scarpi E; Dubini A; Matteucci F; Sanna S
Technol Cancer Res Treat; 2012 Apr; 11(2):163-7. PubMed ID: 22335410
[TBL] [Abstract][Full Text] [Related]
18. The radiology of thoracic malignant mesothelioma.
Wechsler RJ; Rao VM; Steiner RM
Crit Rev Diagn Imaging; 1984; 20(4):283-310. PubMed ID: 6723346
[TBL] [Abstract][Full Text] [Related]
19. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma.
Tsutani Y; Takuwa T; Miyata Y; Fukuoka K; Hasegawa S; Nakano T; Okada M
Ann Oncol; 2013 Apr; 24(4):1005-10. PubMed ID: 23136224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
